Clinicopathological characteristics of breast cancer patients with NOD2 mutation according to age

Código QR

Clinicopathological characteristics of breast cancer patients with NOD2 mutation according to age

Guardado en:

Detalles Bibliográficos
Autores principales:	Joanna Huszno, Zofia Kolosza, Marta Nycz-Bochenek, Małgorzata Lisik, Magdalena Mazur, Jolanta Pamuła-Piłat, Ewa Grzybowska
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2020
Materias:	breast cancer nod2 mutation family history of cancer Medicine R
Acceso en línea:	https://doaj.org/article/8ebd083b7a294037923a5991effe4fd7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI–positive H. pylori
por: Gonzalez–Hormazabal,Patricio, et al.
Publicado: (2021)

NOD1/NOD2 and RIP2 Regulate Endoplasmic Reticulum Stress-Induced Inflammation during <italic toggle="yes">Chlamydia</italic> Infection
por: Oanh H. Pham, et al.
Publicado: (2020)

Risk Factors for Nodding Syndrome and Other Forms of Epilepsy in Northern Uganda: A Case-Control Study
por: Nolbert Gumisiriza, et al.
Publicado: (2021)

BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
por: Lara,Karlena, et al.
Publicado: (2012)

Analysis of 5382insC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer
por: JARA,LILIAN, et al.
Publicado: (2002)

Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis
por: Silvia González-Martínez, et al.
Publicado: (2021)

The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia
por: Tatiana N. Sokolova, et al.
Publicado: (2021)

STRUCTURE AND ADJUVANTICITY IMMUNE PROPERTIES OF MURAMYLDIPEPTIDE
por: V. S. Polovinkina, et al.
Publicado: (2012)

NOD/scid IL‐2Rγnull mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype
por: Anna‐Lena Unterweger, et al.
Publicado: (2021)

Frecuencia de la mutación 185delAG en el gen BRCA1 en mujeres chilenas sanas con antecedentes familiares de cáncer de mama
por: Jara S,Lilian, et al.
Publicado: (2002)

The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
por: Natalya V. Mazurina, et al.
Publicado: (2021)

Molecular-Genetic Aspects of Breast Cancer
por: Krasteva M., et al.
Publicado: (2014)

Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions
por: Yifan Su, et al.
Publicado: (2021)

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer
por: Ziwen Zhang, et al.
Publicado: (2021)

Breast cancer

Current medical literature.

Inhibition of NOD1 Attenuates Neonatal Hypoxia-Ischemia Induced Long-Term Cognitive Impairments in Mice Through Modulation of Autophagy-Related Proteins
por: Liu F, et al.
Publicado: (2021)

Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study
por: Ayoub NM, et al.
Publicado: (2021)

Discovery of a novel potentially transforming somatic mutation in CSF2RB gene in breast cancer
por: Mamoon Rashid, et al.
Publicado: (2021)

Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations
por: Jara,Lilian, et al.
Publicado: (2017)

The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
por: Irina V. Poddubnaya, et al.
Publicado: (2021)

Role and place of PARP inhibitors in the modern treatment algorithm of BRCA-associated HER2-negative metastatic breast cancer. Results of the educational and discussion events based on the “OncoForum” platform
por: Editorial Board
Publicado: (2021)

Advances in breast cancer
Publicado: (2004)

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram
por: Hao Cui, et al.
Publicado: (2021)

Opioids and Breast Cancer Recurrence: A Systematic Review
por: Merlino Lucia, et al.
Publicado: (2021)

Nucleotide Oligomerization Domain-like receptor 4 (NLR4) Gene Expression and Interleukin 1-β (IL 1-β) Level in Urine Samples Before and After Intravesical BCG Therapy For Treatment of Bladder Cancer
por: Ahmed Samar Abd Elmoaty Eissa, et al.
Publicado: (2021)

Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population
por: Lu Shen, et al.
Publicado: (2021)

International journal of breast cancer

Radiological Breast Evaluation Following Breast Reduction Surgery
por: Gaye Toplu, et al.
Publicado: (2021)

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
por: Abdulwahab Abuderman, et al.
Publicado: (2020)

Data provision of PIK3CA gene diversity and recombinant plasmids preparation for control DNA in developing the trastuzumab predictive response diagnostic kit
por: DESRIANI DESRIANI, et al.
Publicado: (2016)

TIFA Signaling in Gastric Epithelial Cells Initiates the <italic toggle="yes">cag</italic> Type 4 Secretion System-Dependent Innate Immune Response to <italic toggle="yes">Helicobacter pylori</italic> Infection
por: Alevtina Gall, et al.
Publicado: (2017)

Evaluating the Risk of Breast Cancer Recurrence and Metastasis After Adjuvant Tamoxifen Therapy by Integrating Polymorphisms in Cytochrome P450 Genes and Clinicopathological Characteristics
por: Hui Pang, et al.
Publicado: (2021)

Is There a Correlation between Multiparametric Assessment in Ultrasound and Intrinsic Subtype of Breast Cancer?
por: Magdalena Gumowska, et al.
Publicado: (2021)

Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer
por: Board Editorial
Publicado: (2021)

Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital
por: Ditsatham C, et al.
Publicado: (2016)

ACTUAL ISSUES OF MASTOPATHY DIAGNOSTICS IN LARGE INDUSTRIAL CITY OF CHELYABINSK REGION
por: A. V. Zurochka, et al.
Publicado: (2015)

Precise Identification of Recurrent Somatic Mutations in Oral Cancer Through Whole-Exome Sequencing Using Multiple Mutation Calling Pipelines
por: Li-Han Lin, et al.
Publicado: (2021)

Piqray – basic questions at the start: whom to test? whom to treat? how to treat? Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 29th, 2021
por: Editorial Board
Publicado: (2021)

The Anti-Tumoral Potential of Phosphonate Analog of Sulforaphane in Zebrafish Xenograft Model
por: Magdalena Rudzinska-Radecka, et al.
Publicado: (2021)